Christian Mueller
Corporate Officer/Principal bei IMMUTEP LIMITED
Profil
Christian Mueller is currently working as the SVP-Regulatory & Strategy at Immutep Ltd.
Previously, he worked as a Project Manager at Medical Enzymes AG.
He graduated from the Technical University of Berlin.
Aktive Positionen von Christian Mueller
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUTEP LIMITED | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Christian Mueller
| Unternehmen | Position | Ende |
|---|---|---|
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - |
Ausbildung von Christian Mueller
| Technical University of Berlin | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
